Industry Reviews

Strategic Review of Immunoassays: Seeing Beyond the Market Inflection Point

The immunoassays* (IAS) market, a key growth area within in vitro diagnostics, is at an inflection point and likely to experience attractive growth in coming years driven primarily by the next generation of advanced medical testing technologies. With the market poised for accelerated growth, many diagnostics companies must adjust their portfolios and business models to position themselves for success. In this industry review, Scientia Advisors shares insights from its internal research on the global IAS market and its technology growth drivers, including ultra-sensitive detection, multiplexing, and emerging novel biomarkers. The review also examines the impact of personalized medicine diagnostics and emerging sole service providers on the IAS market. Finally, long term implications for traditional IAS players are discussed.

*Immunoassays are tests that use antibody/antigen reactions to detect and quantify substances associated with particular diseases in blood, urine and other bodily fluids.